Loading...

NeutriSci International Inc.

NRXCF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.001
$0.00(0.00%)

NeutriSci International Inc. (NRXCF) Stock Overview

Explore NeutriSci International Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap842.5M
P/E Ratio-0.39
EPS (TTM)$-0.01
ROE2.32%
Fundamental Analysis

AI Price Forecasts

1 Week$0.00
1 Month$0.00
3 Months$0.01
1 Year Target$0.01

NRXCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NeutriSci International Inc. (NRXCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.39 and a market capitalization of 842.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-96.06%
5-Year Change
-94.32%
All-Time (Max) Change
-99.24%

Contact Information

https://www.neutrisci.com
403 264 6320
1600 – 609 Granville Street, Vancouver, BC, V7Y 1C3

Company Facts

IPO DateSep 7, 2016
CountryCA
Actively Trading

Frequently Asked Questions

;